Encompass Health Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29261A1007
USD
113.02
-0.02 (-0.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,457.70
1,455.40
1,405.00
1,351.00
1,301.20
1,316.00
1,246.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,457.70
1,455.40
1,405.00
1,351.00
1,301.20
1,316.00
1,246.80
Raw Material Cost
1,139.20
1,136.10
1,118.20
1,087.90
1,035.10
1,058.30
1,003.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
767.70
762.30
756.80
732.10
700.50
711.60
676.30
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
30.40
31.80
33.00
34.90
34.30
35.20
34.90
Selling and Distribution Expenses
59.40
52.30
54.50
54.00
50.50
50.20
53.10
Other Expenses
-79.81
-79.41
-78.98
-76.70
-73.48
-74.68
-71.12
Total Expenditure (Excl Depreciation)
1,198.60
1,188.40
1,172.70
1,141.90
1,085.60
1,108.50
1,056.90
Operating Profit (PBDIT) excl Other Income
259.1
267
232.3
209.1
215.6
207.5
189.89999999999998
Other Income
8.10
3.40
2.30
10.00
4.70
6.10
9.80
Operating Profit (PBDIT)
347.10
349.60
312.60
297.50
293.20
283.90
269.80
Interest
30.40
31.80
33.00
34.90
34.30
35.20
34.90
Exceptional Items
0.00
0.00
-0.20
-0.40
0.00
0.00
0.00
Gross Profit (PBDT)
318.50
319.30
286.80
263.10
266.10
257.70
243.00
Depreciation
79.90
79.20
78.00
78.40
72.90
70.30
70.10
Profit Before Tax
236.80
238.60
201.40
183.80
186.00
178.40
164.80
Tax
51.00
41.60
37.60
36.00
38.30
38.30
37.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
142.60
151.60
119.70
108.20
114.50
113.00
96.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
142.60
151.60
119.70
108.20
114.50
113.00
96.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
42.80
45.00
43.30
38.90
32.40
26.30
31.50
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
185.40
196.60
163.00
147.10
146.90
139.30
127.60
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
2,280.10
2,159.10
2,067.00
1,959.80
1,839.40
1,741.90
1,647.50
Earnings per share (EPS)
1.39
1.48
1.18
1.06
1.12
1.1
0.86
Diluted Earnings per share
1.39
1.48
1.18
1.06
1.12
1.1
0.86
Operating Profit Margin (Excl OI)
17.77%
18.35%
16.53%
15.48%
16.57%
15.77%
15.23%
Gross Profit Margin
21.73%
21.84%
19.89%
19.41%
19.9%
18.9%
18.84%
PAT Margin
9.78%
10.42%
8.52%
8.01%
8.8%
8.59%
7.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.16% vs 3.59% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -5.70% vs 20.61% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -2.08% vs 11.57% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -4.40% vs -3.64% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Encompass Health Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,457.70
1,394.98
62.72
4.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,457.70
1,394.98
62.72
4.50%
Raw Material Cost
1,139.20
1,454.73
-315.53
-21.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
767.70
0.00
767.70
Power Cost
0
0
0.00
Manufacturing Expenses
30.40
1.57
28.83
1,836.31%
Selling and Distribution Expenses
59.40
56.16
3.24
5.77%
Other Expenses
-79.81
-0.16
-79.65
-49,781.25%
Total Expenditure (Excl Depreciation)
1,198.60
1,510.89
-312.29
-20.67%
Operating Profit (PBDIT) excl Other Income
259.10
-115.91
375.01
323.54%
Other Income
8.10
13.29
-5.19
-39.05%
Operating Profit (PBDIT)
347.10
-95.30
442.40
464.22%
Interest
30.40
1.57
28.83
1,836.31%
Exceptional Items
0.00
-0.12
0.12
100.00%
Gross Profit (PBDT)
318.50
-59.75
378.25
633.05%
Depreciation
79.90
7.32
72.58
991.53%
Profit Before Tax
236.80
-104.31
341.11
327.02%
Tax
51.00
0.06
50.94
84,900.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
142.60
-104.37
246.97
236.63%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
142.60
-104.37
246.97
236.63%
Share in Profit of Associates
0
0
0.00
Minority Interest
42.80
0.00
42.80
Other related items
0.00
0.00
0.00
Consolidated Net Profit
185.40
-104.37
289.77
277.64%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
2,280.10
408.93
1,871.17
457.58%
Earnings per share (EPS)
1.39
-0.25
1.64
656.00%
Diluted Earnings per share
1.39
-0.25
1.64
656.00%
Operating Profit Margin (Excl OI)
17.77%
-8.31%
0.00
26.08%
Gross Profit Margin
21.73%
-6.95%
0.00
28.68%
PAT Margin
9.78%
-7.48%
0.00
17.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 145.77 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.16% vs 3.59% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.03% vs 9.61% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 18.54 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -5.70% vs 20.61% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 26.21% vs 24.70% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.90 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.08% vs 11.57% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 17.50% vs 12.48% in Jun 2024

Quarterly - Interest
Interest 3.04 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -4.40% vs -3.64% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -11.37% vs -5.51% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.77%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024